Frontage Holdings Corporation
HKSE: 1521.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Zhongping Lin
- Employees
- 1,560
- Headquarters
- Exton, United States
- IPO year
- 2019
- Market cap
- HK$2.0B
- Website
- https://www.frontagelab.com
Loading 1521…
Loading profile data…Frequently asked questions about 1521
What does Frontage Holdings Corporation (1521.HK) do?
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry...
Where does 1521.HK trade?
Frontage Holdings Corporation (1521.HK) trades on the Hong Kong Stock Exchange.
What sector is 1521.HK in?
Frontage Holdings Corporation (1521.HK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Frontage Holdings Corporation?
Zhongping Lin is the chief executive officer of Frontage Holdings Corporation (1521.HK).
Where is Frontage Holdings Corporation headquartered?
Frontage Holdings Corporation is headquartered in United States.
Does 1521.HK pay a dividend?
Frontage Holdings Corporation (1521.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 1521.HK go public?
Frontage Holdings Corporation (1521.HK) completed its initial public offering in 2019.